This Notice of Funding Opportunity Announcement (NOFO), NCI Transition Career Development Award to Promote Diversity (K22) supports senior postdoctoral fellows or individuals in similar mentored roles who have not yet gained independence, helping them transition into assistant professor or equivalent roles. The program's goal is to establish successful careers for these individuals as independent research scientists.
This NOFO is specifically designed to support individuals from diverse backgrounds, including those whose life experiences, geographic location, socioeconomic status, academic training, professional experience, disability status, military service, career stage, institutional affiliation, cultural background, and other factors contribute to a diverse and inclusive research workforce (NOT-OD-20-031). It provides salary and research support for up to three years of 'protected time,' dedicated to intensive research and career development during their transition into independent research careers.
This Notice of Funding Opportunity (NOFO) is designed specifically to support candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Candidates not planning to lead an independent clinical trial but intending to gain experience in a trial led by another investigator should apply to the companion NOFO ( PAR-24-317 ).
PAR-24-318 Expiration Date: January 08, 2028
Postdoctoral Investigators: At the time of the initial application submission, candidates for this award must: (1) have earned a terminal clinical or research doctorate (including PhD, MD, DO, DC, ND, DDS, DMD, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) or a combined research doctorate/clinical degree; (2) have at least 2 years of postdoctoral training in cancer research at the time of submission of the initial application (e.g., postdoctoral fellow, postdoctoral associate, clinical fellow, clinical associate or equivalent); and (3) have Early-Stage Investigator status (ESI) in their eRA Commons account.
Clinicians (including those with M.D., D.D.S, D.V.M. and other licensed professionals) in positions not designated as postdoctoral positions: Following clinical training or fellowship training periods, clinicians often obtain a clinical faculty position that denotes independence in clinical responsibilities but not in research. Time spent in clinical training is not counted for the postdoctoral research experience limit. Clinical faculty member who does not hold an independent research faculty position may be eligible to receive support from this K22 funding program, and should contact the NCI Program Director listed in Section VII for guidance. Clinicians in such positions are encouraged to obtain confirmation of their eligibility before they begin to work with their organization to prepare an application. Such individuals may also wish to consider other career awards (see K Kiosk) available to support junior faculty development.
Other Candidates: Some institutions appoint postdoctoral fellows in positions with other titles (e.g., research associate, instructor, or equivalent) but they are still in mentored training positions. Candidates in such positions are encouraged to obtain confirmation of their eligibility before they begin to work with their organization to prepare an application. It is incumbent upon the candidate to provide evidence that he/she is in a position that is equivalent to that of a post-doctoral scientist.
Investigators trained in Mathematics, Physical Sciences and/or Engineering may want to consider re-orienting to cancer-focused research careers. Such investigators should have some prior training in cancer research to be competitive for this non-mentored K22 grant.
Career Stage: This funding program is specifically intended to support mid-career cancer researcher. The candidates should have at least two years of research training or experience beyond their doctoral degree. Additionally, they must have early-stage investigator (ESI) status at the time of the application submission due date. Candidates can check their ESI status and ESI expiration date in their eRA Commons account and may request an ESI extension under special circumstances. Please visit the ESI extension web page for more details.
Individuals are eligible for support from a K22 award if they have been, or currently are, the PD/PI of an NIH R03, K12, KL2, K32 or R21 grant or a PHS or non-Federal award equivalent. Individuals are NOT eligible to apply as candidates if they have pending an application for support from any other PHS career development award, an NIH institute-specific K22, or a Pathway to Independence Award (K99/R00). Individuals are not eligible to apply as candidates if they have been or are currently a PD/PI on an NIH R01-equivalent award project grant or a sub-project leader on a Program Project (P01) or Center Grant (P50), or a non-NIH equivalent to these grants/awards.
Eligible Countries:
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 08, 2028
$50,000
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Website URL: https://grants.nih.gov/grants/guide/notice-files/NOT-AA-24-007.html
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.